Kallmann Syndrome
Kallmann syndrome is a form of hypogonadism, which refers to a condition marked by a lowered functioning of the glands producing sex hormones. The condition is believed to be caused due to a shortage of gonadotropin-releasing hormone, which is secreted by the hypothalamus. Kallmann syndrome is also referred to as hypothalamic hypogonadism, hypogonadotropic hypogonadism as well as familial hypogonadism with anosmia, revealing its disease mechanism.
Kallmann syndrome is an example of secondary hypogonadism revealing the fact that the major reason behind the defect in the production of sex hormone is present within the pituitary and the hypothalamus instead of a physical defect on part of the testes or ovaries. The syndrome was first explained by Franz Josef Kallmann in 1944. He was a German-American geneticist, who did a tremendous job in this direction.
The syndrome is characterized by features like Hypogonadotropic hypogonadism, which is a lack of the pituitary hormones, as well as congenital anosmia, which refers to a complete inability to smell, apart from hyposmia. It can also at times be accompanied by optic problems like nerve deafness, mirror movement disorder, color blindness, as well as optic atrophy, renal agenesis, cleft palate, or cryptorchidism.
As it is, it is not known, whether these problems have the same root cause as the hypogonadism and anosmia. Such problems are quite often present among those without Kallmann syndrome.
In case of males the syndrome may result in delayed puberty, along with micro penis. However, congenital micro penis does not feature in the majority of cases of male Kallmann syndrome. In case of females they may show up delayed puberty, along with a lack of secondary sex features like breast development.
In a few of the cases, it might manifest post-pubertal onset, resulting in a phenotypically normal penis in case of men with ensuing testicular atrophy, as well as loss of some secondary sex traits. Such men are usually suffering from sexual impairment, along with low libido. In case of women, a late onset of Kallmann Syndrome might cause secondary amenorrhea. In such cases, Anosmia may or may not be present.
Treatment in case of Kallmann Syndrome focuses around restoring the deficient hormones, which is also known as hormone therapy. As it is, males are treated with human chorionic gonadotropin and testosterone. Females are administered with oestrogen, or progestins. In order to induce fertility in case of males or females, GnRH is infused inside the body, with the help of an infusion pump. As it is, fertility is only restored at the same time as actually being administered with these hormones.
